Published in Proc Natl Acad Sci U S A on October 13, 1998
The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics (2005) 2.40
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med (2001) 2.27
Targeting proteins for degradation. Nat Chem Biol (2009) 2.22
The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study. Proc Natl Acad Sci U S A (1999) 1.62
The proteasome activator 11 S REG (PA28) and class I antigen presentation. Biochem J (2000) 1.62
Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J Exp Med (2000) 1.59
Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors. Proc Natl Acad Sci U S A (2001) 1.58
Regulated protein turnover: snapshots of the proteasome in action. Nat Rev Mol Cell Biol (2014) 1.57
The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med (2001) 1.53
The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell Mol Life Sci (2011) 1.35
Sequence- and species-dependence of proteasomal processivity. ACS Chem Biol (2012) 1.18
The inside-out mechanism of Dicers from budding yeasts. Cell (2011) 1.15
A kinetic model of vertebrate 20S proteasome accounting for the generation of major proteolytic fragments from oligomeric peptide substrates. Biophys J (2000) 1.12
Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition. Proc Natl Acad Sci U S A (2009) 1.07
Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity. Proc Natl Acad Sci U S A (2000) 1.07
ER stress affects processing of MHC class I-associated peptides. BMC Immunol (2009) 1.02
Mass spectrometry analysis of proteome-wide proteolytic post-translational degradation of proteins. Anal Chem (2008) 1.02
Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes. J Exp Med (2000) 1.01
The ubiquitin ligase Hul5 promotes proteasomal processivity. Mol Cell Biol (2009) 0.98
Bivalency as a principle for proteasome inhibition. Proc Natl Acad Sci U S A (1999) 0.96
Computational analysis and modeling of cleavage by the immunoproteasome and the constitutive proteasome. BMC Bioinformatics (2010) 0.94
Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome. Immunogenetics (2003) 0.93
Simultaneous fluorescent monitoring of proteasomal subunit catalysis. J Am Chem Soc (2010) 0.92
Regulatory role of proteasome in determination of platelet life span. J Biol Chem (2013) 0.91
N-glycosylation enhances presentation of a MHC class I-restricted epitope from tyrosinase. J Immunol (2009) 0.90
Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activity. Biochem J (2004) 0.89
Driving forces of proteasome-catalyzed peptide splicing in yeast and humans. Mol Cell Proteomics (2012) 0.89
Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes. BMC Genomics (2010) 0.89
Discriminating self from nonself with short peptides from large proteomes. Immunogenetics (2004) 0.88
A mathematical model of protein degradation by the proteasome. Biophys J (2005) 0.87
Proteasome proteolysis supports stimulated platelet function and thrombosis. Arterioscler Thromb Vasc Biol (2013) 0.85
Bacterial Proteasomes. Annu Rev Microbiol (2015) 0.85
The origin of proteasome-inhibitor resistant HLA class I peptidomes: a study with HLA-A*68:01. Mol Cell Proteomics (2011) 0.84
Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors. BMC Cancer (2011) 0.83
The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference. J Immunol (2016) 0.82
Human Tumor Antigens and Cancer Immunotherapy. Biomed Res Int (2015) 0.81
PA28αβ: the enigmatic magic ring of the proteasome? Biomolecules (2014) 0.81
Covalent complexes of proteasome model with peptide aldehyde inhibitors MG132 and MG101: docking and molecular dynamics study. J Mol Model (2009) 0.81
A melanoma multiepitope polypeptide induces specific CD8+ T-cell response. Cell Immunol (2008) 0.80
Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex. Biomolecules (2014) 0.79
Posttranslational modification and cell type-specific degradation of varicella-zoster virus ORF29p. J Virol (2006) 0.79
Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone. J Biomed Biotechnol (2003) 0.79
Optimal length transportation hypothesis to model proteasome product size distribution. J Biol Phys (2006) 0.78
Protein folding and the order/disorder paradox. J Cell Biochem (2011) 0.78
Proteasome inhibitors alter levels of intracellular peptides in HEK293T and SH-SY5Y cells. PLoS One (2014) 0.78
The VHSE-based prediction of proteasomal cleavage sites. PLoS One (2013) 0.76
Computational prediction of cleavage using proteasomal in vitro digestion and MHC I ligand data. J Zhejiang Univ Sci B (2013) 0.76
Force spectroscopy of substrate molecules en route to the proteasome's active sites. Biophys J (2011) 0.75
Harnessing proteasome dynamics and allostery in drug design. Antioxid Redox Signal (2014) 0.75
Bortezomib alleviates experimental pulmonary hypertension by regulating intracellular calcium homeostasis in PASMCs. Am J Physiol Cell Physiol (2016) 0.75
Dual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens. Sci Rep (2017) 0.75
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Multiple significance tests: the Bonferroni method. BMJ (1995) 23.46
Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science (1995) 12.94
Structure of 20S proteasome from yeast at 2.4 A resolution. Nature (1997) 12.73
Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem (1996) 10.70
Conformational preferences of amino acids in globular proteins. Biochemistry (1978) 4.00
Methods and algorithms for statistical analysis of protein sequences. Proc Natl Acad Sci U S A (1992) 3.63
The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. J Biol Chem (1997) 2.85
The characterization of amino acid sequences in proteins by statistical methods. J Theor Biol (1968) 2.75
Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J Biol Chem (1992) 2.48
Purification of an 11 S regulator of the multicatalytic protease. J Biol Chem (1992) 2.35
A role for the proteasome regulator PA28alpha in antigen presentation. Nature (1996) 2.30
Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70. J Biol Chem (1997) 2.14
Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J Immunol (1994) 1.85
Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell (1996) 1.76
A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity (1996) 1.58
Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J Biol Chem (1998) 1.57
Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum. J Biol Chem (1997) 1.52
Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides. J Immunol (1989) 1.49
Existence of a molecular ruler in proteasomes suggested by analysis of degradation products. FEBS Lett (1994) 1.32
Range of sizes of peptide products generated during degradation of different proteins by archaeal proteasomes. J Biol Chem (1998) 1.26
The high molecular weight multicatalytic proteinase, macropain, exists in a latent form in human erythrocytes. Biochim Biophys Acta (1989) 1.24
Conformational constraints for protein self-cleavage in the proteasome. J Mol Biol (1998) 1.18
Catalytic properties of 26 S and 20 S proteasomes and radiolabeling of MB1, LMP7, and C7 subunits associated with trypsin-like and chymotrypsin-like activities. J Biol Chem (1997) 1.18
Pituitary multicatalytic proteinase complex. Specificity of components and aspects of proteolytic activity. Biochemistry (1989) 1.17
The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides. Proc Natl Acad Sci U S A (1996) 1.15
Degradation of oxidized insulin B chain by the multiproteinase complex macropain (proteasome). Biochemistry (1991) 1.09
Subunit arrangement in the human 20S proteasome. Proc Natl Acad Sci U S A (1997) 1.06
Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system. J Exp Med (1997) 1.00
A 3,4-dichloroisocoumarin-resistant component of the multicatalytic proteinase complex. Biochemistry (1992) 0.87
Reaction of proteasomes with peptidylchloromethanes and peptidyldiazomethanes. Biochem J (1993) 0.86
SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics (1999) 14.15
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (1991) 13.90
Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science (1995) 12.94
Structure of 20S proteasome from yeast at 2.4 A resolution. Nature (1997) 12.73
X-ray structure analysis of a membrane protein complex. Electron density map at 3 A resolution and a model of the chromophores of the photosynthetic reaction center from Rhodopseudomonas viridis. J Mol Biol (1984) 8.85
Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J Immunol (1985) 7.90
The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. Nature (1998) 7.77
Depressor substances in extracts of intestine. J Physiol (1934) 7.49
Isolation of autophagocytosis mutants of Saccharomyces cerevisiae. FEBS Lett (1994) 6.35
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature (1990) 6.23
A malaria model tested in the African savannah. Bull World Health Organ (1974) 5.74
A gated channel into the proteasome core particle. Nat Struct Biol (2000) 5.42
Structure of the protein subunits in the photosynthetic reaction centre of Rhodopseudomonas viridis at 3Å resolution. Nature (2012) 5.22
ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science (1996) 5.13
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature (1989) 5.08
Oxygen stress: a regulator of apoptosis in yeast. J Cell Biol (1999) 4.76
Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet (1996) 4.62
The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J (1989) 4.49
Fourier Domain Mode Locking (FDML): A new laser operating regime and applications for optical coherence tomography. Opt Express (2006) 4.49
The structures of HsIU and the ATP-dependent protease HsIU-HsIV. Nature (2000) 4.46
Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature (1997) 4.40
Aut2p and Aut7p, two novel microtubule-associated proteins are essential for delivery of autophagic vesicles to the vacuole. EMBO J (1998) 4.38
Structure of bovine pancreatic trypsin inhibitor. Results of joint neutron and X-ray refinement of crystal form II. J Mol Biol (1984) 4.14
Proteasome from Thermoplasma acidophilum: a threonine protease. Science (1995) 3.62
Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol (1984) 3.60
The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature (2000) 3.53
Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet (2001) 3.36
Der1, a novel protein specifically required for endoplasmic reticulum degradation in yeast. EMBO J (1996) 3.34
Der3p/Hrd1p is required for endoplasmic reticulum-associated degradation of misfolded lumenal and integral membrane proteins. Mol Biol Cell (1998) 3.33
Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature (1990) 3.32
Crystallographic refinement and atomic models of two different forms of citrate synthase at 2.7 and 1.7 A resolution. J Mol Biol (1982) 3.28
Natural protein proteinase inhibitors and their interaction with proteinases. Eur J Biochem (1992) 3.27
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol (2003) 3.25
Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution. J Mol Biol (1980) 3.25
Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. J Mol Biol (1974) 3.17
Proteasomes: destruction as a programme. Trends Biochem Sci (1996) 3.15
Adrenaline in the suprarenal medulla. J Physiol (1933) 3.14
The proteasome. Annu Rev Biophys Biomol Struct (1999) 3.13
Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med (1998) 3.03
Crystallographic structure studies of an IgG molecule and an Fc fragment. Nature (1976) 3.00
Crystal structure of the thermosome, the archaeal chaperonin and homolog of CCT. Cell (1998) 2.94
Exact prediction of a natural T cell epitope. Eur J Immunol (1991) 2.90
Retrograde protein translocation: ERADication of secretory proteins in health and disease. Trends Biochem Sci (1999) 2.89
Low affinity interaction of peptide-MHC complexes with T cell receptors. Science (1991) 2.89
The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. J Biol Chem (1997) 2.85
Structure of the tetrameric restriction endonuclease NgoMIV in complex with cleaved DNA. Nat Struct Biol (2000) 2.82
Crystal structure of a carbon monoxide dehydrogenase reveals a [Ni-4Fe-5S] cluster. Science (2001) 2.78
MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology (2000) 2.77
The structure of a complex of recombinant hirudin and human alpha-thrombin. Science (1990) 2.71
PRE2, highly homologous to the human major histocompatibility complex-linked RING10 gene, codes for a yeast proteasome subunit necessary for chrymotryptic activity and degradation of ubiquitinated proteins. J Biol Chem (1993) 2.71
Structure and mechanism of the aberrant ba(3)-cytochrome c oxidase from thermus thermophilus. EMBO J (2000) 2.71
Structure determination and refinement of human alpha class glutathione transferase A1-1, and a comparison with the Mu and Pi class enzymes. J Mol Biol (1993) 2.66
The medial-Golgi ion pump Pmr1 supplies the yeast secretory pathway with Ca2+ and Mn2+ required for glycosylation, sorting, and endoplasmic reticulum-associated protein degradation. Mol Biol Cell (1998) 2.56
Analysis of two mutated vacuolar proteins reveals a degradation pathway in the endoplasmic reticulum or a related compartment of yeast. Eur J Biochem (1993) 2.55
Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry (1986) 2.52
A structured epidemic model incorporating geographic mobility among regions. Math Biosci (1995) 2.50
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol Immunother (2007) 2.49
Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J Exp Med (1991) 2.48
Amplified, frequency swept lasers for frequency domain reflectometry and OCT imaging: design and scaling principles. Opt Express (2005) 2.48
The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J (1988) 2.48
Contact tracing in stochastic and deterministic epidemic models. Math Biosci (2000) 2.44
The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J (1990) 2.44
High-level biosynthetic substitution of methionine in proteins by its analogs 2-aminohexanoic acid, selenomethionine, telluromethionine and ethionine in Escherichia coli. Eur J Biochem (1995) 2.44
X-ray crystallographic structure of the light-harvesting biliprotein C-phycocyanin from the thermophilic cyanobacterium Mastigocladus laminosus and its resemblance to globin structures. J Mol Biol (1985) 2.42
Crystal structure of P22 tailspike protein: interdigitated subunits in a thermostable trimer. Science (1994) 2.41
Aortic dissection: a comparative study of diagnosis with spiral CT, multiplanar transesophageal echocardiography, and MR imaging. Radiology (1996) 2.38
The blue oxidases, ascorbate oxidase, laccase and ceruloplasmin. Modelling and structural relationships. Eur J Biochem (1990) 2.37
X-ray crystal structures of cytosolic glutathione S-transferases. Implications for protein architecture, substrate recognition and catalytic function. Eur J Biochem (1994) 2.37
The three-dimensional structure of class pi glutathione S-transferase in complex with glutathione sulfonate at 2.3 A resolution. EMBO J (1991) 2.36
Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology (2001) 2.36
Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol (2004) 2.34
Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell Mol Life Sci (2005) 2.32
A role for the proteasome regulator PA28alpha in antigen presentation. Nature (1996) 2.30
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med (2001) 2.27
Lysosomal (vacuolar) proteinases of yeast are essential catalysts for protein degradation, differentiation, and cell survival. J Biol Chem (1989) 2.25
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5.5 and pH 9.0. A pH-induced conformational transition involves a peptide bond flip. J Mol Biol (1991) 2.19
Crystal structure of a thermostable type B DNA polymerase from Thermococcus gorgonarius. Proc Natl Acad Sci U S A (1999) 2.19
Refined crystal structure of ascorbate oxidase at 1.9 A resolution. J Mol Biol (1992) 2.18
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature (1997) 2.17
Structural homology of reaction centers from Rhodopseudomonas sphaeroides and Rhodopseudomonas viridis as determined by x-ray diffraction. Proc Natl Acad Sci U S A (1986) 2.16
Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci U S A (2001) 2.14
Pyrobaculum aerophilum sp. nov., a novel nitrate-reducing hyperthermophilic archaeum. Appl Environ Microbiol (1993) 2.13
Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med (1995) 2.11
Structure of human des(1-45) factor Xa at 2.2 A resolution. J Mol Biol (1993) 2.07
Refined structure of the hirudin-thrombin complex. J Mol Biol (1991) 2.06
Refined three-dimensional structures of two cyanobacterial C-phycocyanins at 2.1 and 2.5 A resolution. A common principle of phycobilin-protein interaction. J Mol Biol (1987) 2.06
Membrane topology and function of Der3/Hrd1p as a ubiquitin-protein ligase (E3) involved in endoplasmic reticulum degradation. J Biol Chem (2001) 2.04